Clinical Trials Directory

Trials / Unknown

UnknownNCT03107975

Effect of Human Amniotic Epithelial Cells on Children With Spastic Cerebral Palsy

Effect of Intrathecal Transplant of Human Amniotic Epithelial Cells on Children With Spastic Cerebral Palsy

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
The Second Affiliated Hospital of Fujian Medical University · Academic / Other
Sex
All
Age
1 Year – 5 Years
Healthy volunteers
Not accepted

Summary

This study aimed to evaluate the therapeutic potential of human amniotic epithelial cell (hAEC) transplant in the management of children with spastic cerebral palsy.

Detailed description

Cerebral palsy is one of the most common congenital (existing at or before birth) disorders of childhood.Spastic cerebral palsy causes stiffness and movement difficulties.There is no cure for the disease now. This study aimed to evaluate the therapeutic potential of human amniotic epithelial cell (hAEC) transplant in the management of children with spastic cerebral palsy. hAEC will be intrathecal transplanted. Functional status is determined by Gross Motor Function Measure-66 and Fine Motor Function Measure. Spasticity is evaluated by using modified Ashworth scale(MAS).

Conditions

Interventions

TypeNameDescription
BIOLOGICALhuman amniotic epithelial cellsintrathecal injection of human amniotic epithelial cells

Timeline

Start date
2017-04-01
Primary completion
2017-12-31
Completion
2018-12-31
First posted
2017-04-11
Last updated
2017-04-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03107975. Inclusion in this directory is not an endorsement.